OTC product search, selection and in-licensing
Client: International OTC company

The challenge

The client had a portfolio of older OTC and wanted to modernise it with newer and best-in-class therapies. However, they had no in-house R&D, licensing or business development expertise. So our challenge was not only to identify new products, but to license them in with a good margin, to improve profitability and support TV and global ad campaigns.

Our approach

We have strong capabilities in this area, due to our knowledge management know-how and extensive partner search and selection tools. Here, our role was to advise and support the board in their strategic decision-making. We achieved this by:

• Undertaking competitor analysis
• Evaluating opportunities for new business
• Formulating new product development strategies and recommendations
• Assessing licensing and production opportunities
• Sourcing and negotiating rights to suitable products

There are a number of opportunities in the generic sector for OTC switches.
Using the above methodology we were able to source cost effective, high-margin products with first-to-market status and prolonged exclusivity, and a global rollout and regulatory strategy in place.

Result

With Pharmawise on board, the client had the advantage of:

• Having the first branded generic to market
• Prolonged exclusivity, as only two manufacturers in world made this product
• Full focus on marketing, a core company function

The outcome: a very successful move for our clients!

‍

‍

‍